June 5, 2007 - GVI Medical Devices, Inc., extended its nuclear cardiology line with the introduction of ClearVision SPECT imaging system, designed to offer cost-effective diagnostic cardiac imaging.
The system performs upright or seated patient imaging using an open design optimized for acquisition accuracy and patient comfort. The system is capable of imaging patients up to 500 pounds and has a compact footprint of just 3x6, designed for smaller spaces. The scanner is available in both a single or dual detector configuration, complete with its “RESOLVE” technology, which incorporates a new standard for at–depth resolution and signal-to-noise ratio.


Additional Content

News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | Radiopharmaceuticals and Tracers

June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...

Time June 01, 2026
arrow
News | SNMMI

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los ...

Time April 07, 2026
arrow
News | PET Imaging

March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is ...

Time April 06, 2026
arrow
Subscribe Now